✦ LIBER ✦
Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease
✍ Scribed by Song, S.-N. J.; Tomosugi, N.; Kawabata, H.; Ishikawa, T.; Nishikawa, T.; Yoshizaki, K.
- Book ID
- 121697161
- Publisher
- American Society of Hematology
- Year
- 2010
- Tongue
- English
- Weight
- 306 KB
- Volume
- 116
- Category
- Article
- ISSN
- 0006-4971
No coin nor oath required. For personal study only.